A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
There is an unsatisfied medical need for a first-line treatment of lymphatic malformations
with a good benefit/risk profile. Based on a patient experience in the institution, the
investigators plan to verify whether or not the medication sildenafil has a beneficial effect
on lymphatic malformations. The investigators plan to do this by treating patients with
lymphatic malformations with the medication sildenafil for a 20 week period. This is an
investigator initiated study funded by an Innovations in Patient Care grant and a SPARK
grant.